|
TAF11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
2.13530000003903E-06 |
| Normal-vs-Stage3 |
1.00260022506404E-10 |
| Normal-vs-Stage4 |
1.35919999699752E-08 |
| Stage1-vs-Stage2 |
6.374500E-02 |
| Stage1-vs-Stage3 |
1.837530E-02 |
| Stage1-vs-Stage4 |
2.995500E-03 |
| Stage2-vs-Stage3 |
9.514600E-01 |
| Stage2-vs-Stage4 |
5.894000E-01 |
| Stage3-vs-Stage4 |
4.823800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.86320000433926E-08 |
| Normal-vs-Asian |
2.855600E-02 |
| Caucasian-vs-AfricanAmerican |
6.461800E-01 |
| Caucasian-vs-Asian |
8.896800E-01 |
| AfricanAmerican-vs-Asian |
9.681200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
3.583700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.623700E-03 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.261520E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.695400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.603200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.776600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.994200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.846400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.334200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.6286971771251E-12 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
2.22044604925031E-15 |
| Normal-vs-Grade 4 |
8.417400E-04 |
| Grade 1-vs-Grade 2 |
9.364300E-02 |
| Grade 1-vs-Grade 3 |
6.158300E-03 |
| Grade 1-vs-Grade 4 |
2.44969999999567E-05 |
| Grade 2-vs-Grade 3 |
4.958600E-04 |
| Grade 2-vs-Grade 4 |
1.67749999446798E-08 |
| Grade 3-vs-Grade 4 |
5.200700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
1.28860000003783E-06 |
| ccA subtype-vs-ccB subtype |
1.65933933260476E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.705850E-01 |
| N0-vs-N1 |
3.024100E-02 |
|
|
